Rakovina Therapeutics Inc. | Finanzwire

Basculer en Français

11053	Companies
242378	Keywords
170680	Articles
130471	Press releases

Headlines Articles Press releases Rakovina Therapeutics Inc.

Home
Companies
Rakovina Therapeutics Inc.

BRIEF

published on 09/02/2026 at 18:53, 20 days 7 hours ago

Rakovina Therapeutics Inc. Receives Downgrade from First Berlin Equity Research

Licensing Deal Price Target Revision Rakovina Therapeutics AI-powered Pipeline Kt-5000 Program
PRESS RELEASE

published on 09/02/2026 at 18:48, 20 days 7 hours ago

Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Add
First Berlin Equity Research downgrades Rakovina Therapeutics Inc. to ADD and lowers price target to CAD 0.25 in latest research update

First Berlin Equity Research Research Update Price Target Rakovina Therapeutics Inc. Stock Downgrade
BRIEF

published on 04/02/2025 at 15:36, 1 year 5 months ago

Rakovina Therapeutics Receives Buy Rating from First Berlin Equity Research

Artificial Intelligence DNA Damage Response Rakovina Therapeutics PARP And ATR Biotech Investment
PRESS RELEASE

published on 04/02/2025 at 15:31, 1 year 5 months ago

Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Rakovina Therapeutics Inc. with a Buy recommendation and CAD 0.40 target price. Rakovina focuses on DNA Damage Response pathways in developing next-gen cancer treatments

First Berlin Equity Research Buy Recommendation Rakovina Therapeutics Inc. DNA Damage Response Pathways CAD 0.40 Target Price

Accesswire

Published on 09/23/2026 at 02:00, 14 minutes ago

Battery X Metals Announces up to $1 Million Private Placement Financing to Advance Corporate Growth Initiatives
Published on 09/23/2026 at 00:00, 2 hours 14 minutes ago

Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
Published on 09/23/2026 at 00:00, 2 hours 14 minutes ago

Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
Published on 09/22/2026 at 23:10, 3 hours 4 minutes ago

Global Atomic Announces Proposed Public Offering of Units
Published on 09/22/2026 at 22:30, 3 hours 44 minutes ago

Silver Spruce Receives TSXV Conditional Approval of Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 19:40, 6 hours 33 minutes ago

EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 7 hours 14 minutes ago

LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:30, 7 hours 44 minutes ago

Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 17:45, 8 hours 29 minutes ago

Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform.
Published on 09/22/2026 at 17:40, 8 hours 34 minutes ago

VALBIOTIS SA: Valbiotis announces positive results from the Cardio-Liver clinical study - Commercial launch of ValbiotisPRO® Foie on September 23

Les Echos

Published on 09/22/2026 at 18:10, 8 hours 4 minutes ago

Financial statements - 30 june 2026
Published on 09/22/2026 at 18:00, 8 hours 14 minutes ago

Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 8 hours 29 minutes ago

Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/21/2026 at 18:19, 1 day 7 hours ago

Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 1 day 8 hours ago

Partnership agreement signed between Manitou Group and HD Construction Equipment

View all LES ECHOS COMFI WIRE